{
    "clinical_study": {
        "@rank": "77341", 
        "acronym": "CSM/FAP/2012", 
        "arm_group": {
            "arm_group_label": "Prolonged postoperative air leaks in risk patients.", 
            "arm_group_type": "Experimental", 
            "description": "Implantation of autologous mesenchymal stem cells (CSM) expanded \"in vitro\" and administered directly into the lung suture line"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to analyze the safety and feasibility of the implantation of\n      autologous mesenchymal stem cells (MSCs) expanded \"in vitro\" and administered directly in\n      the lung line of suture as a treatment for patients at risk of postoperative air leaks after\n      lung resection."
        }, 
        "brief_title": "CLINICAL TRIAL PHASE I / II, PROSPECTIVE, OPEN, NONRANDOMIZED, FOR TREATMENT OF POSTOPERATIVE AIR LEAK AFTER LUNG RESECTION IN HIGH RISK PATIENTS THROUGH THE ADMINISTRATION OF MESENCHYMAL AUTOLOGOUS CELLS.", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Prolonged Postoperative Air Leaks in Risk Patients.", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 18 and 70 years\n\n          -  Patients who will be subjected to programmed anatomic lung resection (pneumonectomy\n             excluded)\n\n          -  Patients class C or D on the risk scale of air leak Patients included in the study\n             must meet all inclusion criteria.\n\n        Exclusion Criteria:\n\n        Patients with any of the following exclusion criteria may not be included in the clinical\n        trial:\n\n          -  Those considered by the investigator are not on a good position to tolerate the\n             procedure\n\n          -  Clinical criteria and anesthetics that contraindicate surgery\n\n          -  Uncontrolled severe disease\n\n          -  Pregnant women\n\n          -  Patients infected with hepatitis B, hepatitis C, syphilis and HIV + virus\n\n          -  People who are taking a drug under clinical investigation or participated in any\n             study under clinical investigation (or an authorized product) within 30 days prior to\n             randomization\n\n          -  The absence of informed consent or revocation thereof"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045745", 
            "org_study_id": "CSM/FAP/2012", 
            "secondary_id": "2013-000535-27"
        }, 
        "intervention": {
            "arm_group_label": "Prolonged postoperative air leaks in risk patients.", 
            "intervention_name": "Implantation of autologous mesenchymal stem cells (CSM) expanded \"in vitro\" and administered directly into the lung suture line", 
            "intervention_type": "Genetic"
        }, 
        "keyword": "Prolonged postoperative air leaks in risk patients.", 
        "lastchanged_date": "January 22, 2014", 
        "location": {
            "contact": {
                "email": "ferminsg@usal.es", 
                "last_name": "Ferm\u00edn S\u00e1nchez-Guijo Mart\u00edn, Ph.D", 
                "phone": "+34923294624"
            }, 
            "facility": {
                "address": {
                    "city": "Salamanca", 
                    "country": "Spain", 
                    "state": "Salamanca/Castilla Le\u00f3n", 
                    "zip": "37007"
                }, 
                "name": "University Clinical Hospital of Salamanca"
            }, 
            "investigator": [
                {
                    "last_name": "Marcelo F Jim\u00e9nez L\u00f3pez, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gonzalo Varela Sim\u00f3, Ph.D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Nuria M Novoa Valent\u00edn, Ph.D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jose L Aranda Alcaide, Ph.D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Consuelo del Ca\u00f1izo, Ph.D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ferm\u00edn S\u00e1nchez-Guijo Mart\u00edn, Ph.D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Olga L\u00f3pez Villar, Ph.D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Eva M Villar\u00f3n R\u00edos, Ph.D", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "1", 
        "official_title": "CLINICAL TRIAL PHASE I / II, PROSPECTIVE, OPEN, NONRANDOMIZED, FOR TREATMENT OF POSTOPERATIVE AIR LEAK AFTER LUNG RESECTION IN HIGH RISK PATIENTS THROUGH THE ADMINISTRATION OF MESENCHYMAL AUTOLOGOUS CELLS.", 
        "overall_contact": {
            "email": "ferminsg@usal.es", 
            "last_name": "Ferm\u00edn S\u00e1nchez-Guijo Mart\u00edn, Ph.D", 
            "phone": "+34923294624"
        }, 
        "overall_official": [
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Marcelo F Jim\u00e9nez L\u00f3pez, Ph.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Gonzalo Varela Sim\u00f3, Ph.D", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Nuria M Novoa Valent\u00edn, Ph.D", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Jos\u00e9 L Aranda Alcaide, Ph.D", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Consuelo del Ca\u00f1izo, Ph.D", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Ferm\u00edn S\u00e1nchez-Guijo Mart\u00edn, Ph.D", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Olga L\u00f3pez Villar, Ph.D", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University Clinical Hospital of Salamanca", 
                "last_name": "Eva M Villar\u00f3n R\u00edos, Ph.D", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Spanish Agency of Medicines", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Security is measured in terms of: Adverse effects derived from the implantation of the CSM", 
            "measure": "Safety of the procedure", 
            "safety_issue": "Yes", 
            "time_frame": "During the procedure and postoperative period (48 hours)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045745"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Clinical:\nDuration of postoperative air leak\nAmount of leakage and trends measured by digital memory device\nCardiorespiratory complications\nRadiological:\nPneumothorax on chest radiograph.", 
            "measure": "Analyze the efficacy of the procedure", 
            "safety_issue": "No", 
            "time_frame": "Postoperative period (48 hours), 1 month, 3 months, 6, 12 and 24 months"
        }, 
        "source": "Red de Terapia Celular", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Castilla y Le\u00f3n Hematology and hemotherapy Foundation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Haematology Service,University Hospital of Salamanca, M\u00aaConsuelo del Ca\u00f1izo Fern\u00e1ndez-Rold\u00e1n", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Spanish National Health System", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Red de Terapia Celular", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}